BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Tuesday, January 27, 2026
See today's BioWorld
Home
» Takeda places $100M stake in early stage deal with Gammadelta
To read the full story,
subscribe
or
sign in
.
Takeda places $100M stake in early stage deal with Gammadelta
May 10, 2017
By
Nuala Moran
LONDON – Gammadelta Therapeutics Ltd. has leapt from virtual startup last September to land a $100 million equity, R&D funding and option-to-buy deal with Takeda Pharmaceuticals Co. Ltd.
BioWorld
